These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1890760)

  • 1. [Prospective controlled study of elective sclerotherapy plus oral propranolol for prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage].
    Kanazawa H; Watari A; Matsusaka S; Tada N; Miyata K; Saitoh H; Yoshizawa M; Kuroda H; Kobayashi M
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jun; 88(6):1341-8. PubMed ID: 1890760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial.
    Alexandrino PT; Alves MM; Pinto Correia J
    J Hepatol; 1988 Oct; 7(2):175-85. PubMed ID: 3057063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy.
    Fleig WE; Stange EF; Hunecke R; Schönborn W; Hurler U; Rainer K; Gaus W; Ditschuneit H
    Hepatology; 1987; 7(2):355-61. PubMed ID: 3549507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
    Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial.
    Avgerinos A; Rekoumis G; Klonis C; Papadimitriou N; Gouma P; Pournaras S; Raptis S
    J Hepatol; 1993 Sep; 19(2):301-11. PubMed ID: 8301065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial.
    Ink O; Martin T; Poynard T; Reville M; Anciaux ML; Lenoir C; Marill JL; Labadie H; Masliah C; Perrin D
    Hepatology; 1992 Oct; 16(4):912-9. PubMed ID: 1398497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding.
    Westaby D; Polson RJ; Gimson AE; Hayes PC; Hayllar K; Williams R
    Hepatology; 1990 Mar; 11(3):353-9. PubMed ID: 2179096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy.
    Rossi V; Calès P; Burtin P; Charneau J; Person B; Pujol P; Valentin S; D'Aubigny N; Joubaud F; Boyer J
    J Hepatol; 1991 May; 12(3):283-9. PubMed ID: 1940256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
    Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
    Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Propranolol for prophylaxis of first hemorrhage in cirrhotic patients with esophageal varices--a controlled study comparing with sclerotherapy].
    Kanazawa H; Watari A; Tada N; Matsusaka S; Nakatsuka K; Saitoh H; Yoshizawa M; Kuroda H; Kobayashi M; Nomura T
    Nihon Shokakibyo Gakkai Zasshi; 1993 Sep; 90(9):2067-75. PubMed ID: 8411742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study].
    Dollet JM; Champigneulle B; Patris A; Bigard MA; Gaucher P
    Gastroenterol Clin Biol; 1988 Mar; 12(3):234-9. PubMed ID: 3259521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial.
    Terés J; Bosch J; Bordas JM; Garcia Pagán JC; Feu F; Cirera I; Rodés J
    Gastroenterology; 1993 Nov; 105(5):1508-14. PubMed ID: 8224655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients].
    Poynard T; Aubert A; Naveau S; Lemman M; Chaput JC
    Gastroenterol Clin Biol; 1988 Dec; 12(12):899-905. PubMed ID: 3069544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study.
    Lo GH; Lai KH; Lee SD; Tsai YT; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(4):358-62. PubMed ID: 8374092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: a prospective multicenter randomized trial.
    Avgerinos A; Armonis A; Manolakopoulos S; Rekoumis G; Argirakis G; Viazis N; Vlachogiannakos J; Adamopoulos A; Kanaghinis T; Raptis SA
    Gastrointest Endosc; 2000 Jun; 51(6):652-8. PubMed ID: 10840295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of endoscopic ligation plus cyanoacrylate injection with or without sclerotherapy for variceal bleeding.
    Chen J; Zeng XQ; Ma LL; Huang XQ; Tseng YJ; Wang J; Luo TC; Chen SY
    J Dig Dis; 2016 Apr; 17(4):252-9. PubMed ID: 26896761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration.
    Vinel JP; Lamouliatte H; Cales P; Combis JM; Roux D; Desmorat H; Pradere B; Barjonet G; Quinton A
    Gastroenterology; 1992 May; 102(5):1760-3. PubMed ID: 1568586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy.
    Acharya SK; Dasarathy S; Saksena S; Pande JN
    J Hepatol; 1993 Sep; 19(2):291-300. PubMed ID: 8301064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. The PROVA Study Group.
    Hepatology; 1991 Dec; 14(6):1016-24. PubMed ID: 1959848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic sclerotherapy versus propranolol in prevention of recurrent variceal bleeding in patients with child's B and C cirrhosis: a preliminary report.
    Dwivedi M; Bhargava DK; Ramachandran K
    Indian J Gastroenterol; 1992 Apr; 11(2):68-70. PubMed ID: 1428034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.